Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, has appointed Robb Lawrence as Vice President of Commercial Strategy. In this senior leadership role, Lawrence will lead the design and development of strategic solutions that optimize patient access and outcomes by navigating the complexities of the global healthcare markets.

“Robb’s level of experience and his commitment to addressing unmet patient needs will be an enormous asset to our leadership team,” Camargo CEO Dan Duffy said. “We look forward to working with him in this newly created role to elevate the commercial solutions that Camargo offers our sponsors as they work to deliver therapies to patients.”

Lawrence brings 20 years of experience in pharmaceutical development, from both the product sponsor and the service provider perspectives. His career has focused on managing products’ commercialization strategies throughout the development life cycle. He most recently served as founder and CEO of TLC Therapeutics, LLC, and Tropical Disease Therapeutics, LLC, where he worked to advance niche reformulations of established medicines and neglected tropical diseases, respectively.